{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:55:44Z","timestamp":1770490544321,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Infectious Diseases"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/s1473-3099(19)30524-9","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T18:40:15Z","timestamp":1573843215000},"page":"e47-e53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services"],"prefix":"10.1016","volume":"20","author":[{"given":"Masoud","family":"Dara","sequence":"first","affiliation":[]},{"given":"Soudeh","family":"Ehsani","sequence":"additional","affiliation":[]},{"given":"Antons","family":"Mozalevskis","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Vovc","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Avellon Calvo","sequence":"additional","affiliation":[]},{"given":"Jordi","family":"Casabona i Barbar\u00e0","sequence":"additional","affiliation":[]},{"given":"Otar","family":"Chokoshvili","sequence":"additional","affiliation":[]},{"given":"Irina","family":"Felker","sequence":"additional","affiliation":[]},{"given":"Sven","family":"Hoffner","sequence":"additional","affiliation":[]},{"given":"Gulmira","family":"Kalmambetova","sequence":"additional","affiliation":[]},{"given":"Ecatarina","family":"Noroc","sequence":"additional","affiliation":[]},{"given":"Natalia","family":"Shubladze","sequence":"additional","affiliation":[]},{"given":"Alena","family":"Skrahina","sequence":"additional","affiliation":[]},{"given":"Rasim","family":"Tahirli","sequence":"additional","affiliation":[]},{"given":"Tengiz","family":"Tsertsvadze","sequence":"additional","affiliation":[]},{"given":"Francis","family":"Drobniewski","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1473-3099(19)30524-9_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cll.2014.02.005","article-title":"Molecular diagnosis of tuberculosis and drug resistance","volume":"34","author":"Lin","year":"2014","journal-title":"Clin Lab Med"},{"key":"10.1016\/S1473-3099(19)30524-9_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.aogh.2015.01.001","article-title":"Molecular Diagnosis of TB in the HIV Positive Population","volume":"80","author":"Vittor","year":"2014","journal-title":"Ann Glob Health"},{"key":"10.1016\/S1473-3099(19)30524-9_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0040-2016","article-title":"Impact of the GeneXpert MTB\/RIF technology on tuberculosis control","author":"Stevens","year":"2017","journal-title":"Microbiol Spect"},{"key":"10.1016\/S1473-3099(19)30524-9_bib4","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1128\/JCM.01257-15","article-title":"Diagnostic performance of the new version (v2.0) of GenoType MTBDRs\/assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study","volume":"53","author":"Tagliani","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S1473-3099(19)30524-9_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S1473-3099(16)30190-6","article-title":"Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project","volume":"16","author":"Zignol","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(19)30524-9_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01354-2017","article-title":"A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis","volume":"50","author":"Miotto","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/S1473-3099(19)30524-9_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-319-64371-7_12","article-title":"Evolution of phenotypic and molecular drug susceptibility testing","volume":"1019","author":"Cirillo","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S1473-3099(19)30524-9_bib8","doi-asserted-by":"crossref","first-page":"e01819","DOI":"10.1128\/mBio.01819-14","article-title":"Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study","volume":"5","author":"Miotto","year":"2014","journal-title":"MBio"},{"key":"10.1016\/S1473-3099(19)30524-9_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41467-017-00721-2","article-title":"A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide","volume":"8","author":"Yadon","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/S1473-3099(19)30524-9_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1101\/gr.128678.111","article-title":"Microevolution of extensively drug-resistant tuberculosis in Russia","volume":"22","author":"Casali","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/S1473-3099(19)30524-9_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing","volume":"379","author":"Walker","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(19)30524-9_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12780","article-title":"Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis","author":"Lange","year":"2018","journal-title":"J Intern Med"},{"issue":"suppl 17","key":"10.1016\/S1473-3099(19)30524-9_bib13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2105-16-S17-S1","article-title":"Identifying representative drug resistant mutants of HIV","volume":"16","author":"Yu","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/S1473-3099(19)30524-9_bib14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","article-title":"Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study","volume":"15","author":"Walker","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(19)30524-9_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2878","article-title":"Evolution and transmission of drug resistant tuberculosis in a Russian population","volume":"46","author":"Casali","year":"2014","journal-title":"Nature Genet"},{"key":"10.1016\/S1473-3099(19)30524-9_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmi.2016.09.008","article-title":"Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review","volume":"23","author":"Papaventsis","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S1473-3099(19)30524-9_bib17","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1128\/JCM.00486-15","article-title":"Rapid whole-genome sequencing of Mycobacterium tuberculosis isolates directly from clinical samples","volume":"53","author":"Brown","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S1473-3099(19)30524-9_bib18","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.7717\/peerj.585","article-title":"Culture-independent detection and characterisation of Mycobacterium tuberculosis and M africanum in sputum samples using shotgun metagenomics on a benchtop sequencer","volume":"2","author":"Doughty","year":"2014","journal-title":"Peer J"},{"key":"10.1016\/S1473-3099(19)30524-9_bib19","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/JCM.02483-16","article-title":"Same-day diagnostic and surveillance data for tuberculosis via whole-genome sequencing of direct respiratory samples","volume":"55","author":"Votintseva","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S1473-3099(19)30524-9_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S1473-3099(18)30496-1","article-title":"Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study","volume":"18","author":"Makhado","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(19)30524-9_bib21","series-title":"HIV assays: laboratory performance and other operational characteristics rapid diagnostic tests (combined detection of hiv-1\/2 antibodies and discriminatory detection of HIV-1 and HIV-2 antibodies","year":"2015"},{"key":"10.1016\/S1473-3099(19)30524-9_bib22","series-title":"Guidelines on hepatitis B and C testing","year":"2017"},{"key":"10.1016\/S1473-3099(19)30524-9_bib23","series-title":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection","year":"2018"},{"key":"10.1016\/S1473-3099(19)30524-9_bib24","series-title":"Political declaration of the UN General Assembly high-level meeting on the fight against tuberculosis. Resolution A\/RES\/73\/3","year":"2018"},{"key":"10.1016\/S1473-3099(19)30524-9_bib25","series-title":"Political declaration on HIV and AIDS: on the fast track to accelerating the fight against HIV and to ending the AIDS epidemic by 2030. Resolution 70\/266","year":"2016"},{"key":"10.1016\/S1473-3099(19)30524-9_bib26","series-title":"Global strategy and targets for tuberculosis prevention, care and control after 2015","year":"2014"},{"key":"10.1016\/S1473-3099(19)30524-9_bib27","series-title":"Global health sector strategy on HIV, 2016\u20132021","year":"2016"},{"key":"10.1016\/S1473-3099(19)30524-9_bib28","series-title":"Global health sector strategy on viral hepatitis 2016\u20132021","year":"2016"},{"key":"10.1016\/S1473-3099(19)30524-9_bib29","series-title":"Roadmap to implement the tuberculosis action plan for the WHO European Region 2016\u20132020. Towards ending tuberculosis and multidrug-resistant tuberculosis (2016)","year":"2016"},{"key":"10.1016\/S1473-3099(19)30524-9_bib30","series-title":"Action plan for the health sector response to HIV in the WHO European Region","year":"2017"},{"key":"10.1016\/S1473-3099(19)30524-9_bib31","series-title":"Action plan for the health sector response to viral hepatitis in the WHO European region","year":"2017"},{"key":"10.1016\/S1473-3099(19)30524-9_bib32","series-title":"Report of the 65th session of the WHO Regional Committee for Europe","year":"2015"},{"key":"10.1016\/S1473-3099(19)30524-9_bib33","series-title":"Report of the 66th session of the WHO Regional Committee for Europe","year":"2016"},{"key":"10.1016\/S1473-3099(19)30524-9_bib34","series-title":"Antiretroviral therapy coverage estimates by WHO region","year":"2018"},{"key":"10.1016\/S1473-3099(19)30524-9_bib35","series-title":"HIV\/AIDS surveillance in Europe 2018\u20132017 data","year":"2018"},{"key":"10.1016\/S1473-3099(19)30524-9_bib36","series-title":"Global tuberculosis report 2018","year":"2018"},{"key":"10.1016\/S1473-3099(19)30524-9_bib37","article-title":"Prevalence of TB\/HIV co-infection in countries except China: a systematic review and meta-analysis","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S1473-3099(19)30524-9_bib38","series-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","year":"2016"},{"key":"10.1016\/S1473-3099(19)30524-9_bib39","series-title":"Progress report 2016. Prevent HIV, Test and Treat all","year":"2016"},{"key":"10.1016\/S1473-3099(19)30524-9_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193577","article-title":"Multidisease testing for HIV and TB using the GeneXpert platform: a feasibility study in rural Zimbabwe","volume":"13","author":"Ndlovu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S1473-3099(19)30524-9_bib41","series-title":"Get on the fast-track. The life cycle approach to HIV. Finding solutions at every stage of life","year":"2016"},{"key":"10.1016\/S1473-3099(19)30524-9_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2013.06.005","article-title":"Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line?","volume":"85","author":"Moore","year":"2013","journal-title":"J Hosp Infect"},{"key":"10.1016\/S1473-3099(19)30524-9_bib43","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.15.2.17324","article-title":"Challenges and opportunities for the implementation of virological testing in resource-limited settings","volume":"15","author":"Roberts","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/S1473-3099(19)30524-9_bib44","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.3390\/diagnostics7010003","article-title":"Implementation of point-of-care diagnostics in rural primary healthcare clinics in South Africa: perspectives of key stakeholders","volume":"7","author":"Mashamba-Thompson","year":"2017","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/S1473-3099(19)30524-9_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12916-014-0173-7","article-title":"Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions","volume":"12","author":"Stevens","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/S1473-3099(19)30524-9_bib46","series-title":"HIV\/AIDS treatment and care in Georgia","year":"2014"},{"key":"10.1016\/S1473-3099(19)30524-9_bib47","series-title":"Global AIDS monitoring 2018\u2014indicators for monitoring the 2016 United Nations political declaration on ending AIDS","year":"2017"},{"key":"10.1016\/S1473-3099(19)30524-9_bib48","series-title":"Ending AIDS: progress towards the 90-90-90 targets","year":"2017"},{"key":"10.1016\/S1473-3099(19)30524-9_bib49","series-title":"Consolidated guidelines on HIV testing services","year":"2015"},{"key":"10.1016\/S1473-3099(19)30524-9_bib50","series-title":"Public health guidance on HIV, hepatitis B and C testing in the EU\/EEA","year":"2018"},{"key":"10.1016\/S1473-3099(19)30524-9_bib51","series-title":"WHO endorses new rapid tuberculosis test","year":"2010"},{"key":"10.1016\/S1473-3099(19)30524-9_bib52","series-title":"WHO prequalification of in vitro diagnostics public report product: Xpert HCV Viral Load with GeneXpert Dx, GeneXpert Infinity-48s, and GeneXpert Infinity-80","year":"2017"},{"key":"10.1016\/S1473-3099(19)30524-9_bib53","series-title":"WHO prequalification of in vitro diagnostics public report product: Xpert HIV-1 qual assay","year":"2016"},{"key":"10.1016\/S1473-3099(19)30524-9_bib54","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1128\/JCM.01806-15","article-title":"Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx assays in comparison to the NucliSens EasyQ HIV-1 v2.0 assay for quantification of HIV-1 viral load","volume":"53","author":"Mor","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S1473-3099(19)30524-9_bib55","doi-asserted-by":"crossref","first-page":"e01673","DOI":"10.1128\/JCM.01673-17","article-title":"Performance of the Xpert HIV-1 viral load assay: a systematic review and meta-analysis","volume":"56","author":"Nash","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S1473-3099(19)30524-9_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2017.01.006","article-title":"Point-of-care testing (POCT) in molecular diagnostics: performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection","volume":"88","author":"Gupta","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/S1473-3099(19)30524-9_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12879-018-3656-x","article-title":"Time delay and associated mortality from negative smear to positive Xpert MTB\/RIF test among TB\/HIV patients: a retrospective study","volume":"19","author":"Lisboa","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S1473-3099(19)30524-9_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19340","article-title":"Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis","volume":"19","author":"Drobniewski","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/S1473-3099(19)30524-9_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-14-2","article-title":"Results from early programmatic implementation of Xpert MTB\/RIF testing in nine countries","volume":"14","author":"Creswell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S1473-3099(19)30524-9_bib61","series-title":"WHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders","year":"2012"},{"key":"10.1016\/S1473-3099(19)30524-9_bib63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(14)61464-1","article-title":"Macroeconomic implications of population ageing and selected policy responses","volume":"385","author":"Bloom","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(19)30524-9_bib64","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(19)30524-9_bib65","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2471\/BLT.17.193375","article-title":"Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"95","author":"Ho","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S1473-3099(19)30524-9_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155256","article-title":"POC CD4 Testing improves linkage to HIV care and timeliness of ART initiation in a public health approach: a systematic review and meta-analysis","volume":"11","author":"Vojnov","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S1473-3099(19)30524-9_bib67","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s10461-015-1097-8","article-title":"Attitudes and acceptability on HIV self-testing among key populations: a literature review","volume":"19","author":"Figueroa","year":"2015","journal-title":"AIDS Behav"},{"issue":"suppl 1","key":"10.1016\/S1473-3099(19)30524-9_bib68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/hiv.12592","article-title":"The COBATEST network: monitoring and evaluation of HIV community-based practices in Europe, 2014\u20132016","volume":"19","author":"Fern\u00e0ndez-L\u00f3pez","year":"2018","journal-title":"HIV Med"},{"key":"10.1016\/S1473-3099(19)30524-9_bib69","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.15.21096","article-title":"A systematic review of evidence to inform HIV prevention interventions among men who have sex with men in Europe","volume":"20","author":"Str\u00f6mdahl","year":"2015","journal-title":"Euro Surveill"},{"issue":"suppl 1","key":"10.1016\/S1473-3099(19)30524-9_bib70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/hiv.12595","article-title":"BCN Checkpoint: same-day confirmation of reactive HIV rapid test with point of care HIV-RNA accelerates linkage to care and reduces anxiety","volume":"19","author":"Meulbroek","year":"2018","journal-title":"HIV Med"},{"key":"10.1016\/S1473-3099(19)30524-9_bib71","series-title":"The Global Fund Strategy 2017\u20132022","year":"2017"},{"key":"10.1016\/S1473-3099(19)30524-9_bib72","series-title":"Building resilient and sustainable systems for health through global fund investments information","year":"2017"},{"key":"10.1016\/S1473-3099(19)30524-9_bib74","series-title":"Changing diagnostic paradigms for microbiology: report on an American academy of microbiology colloquium held in Washington, DC, from 17 to 18 October 2016","author":"Dolen","year":"2017"}],"container-title":["The Lancet Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309919305249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309919305249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T09:29:28Z","timestamp":1761470968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309919305249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1473309919305249"],"URL":"https:\/\/doi.org\/10.1016\/s1473-3099(19)30524-9","relation":{},"ISSN":["1473-3099"],"issn-type":[{"value":"1473-3099","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services","name":"articletitle","label":"Article Title"},{"value":"The Lancet Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1473-3099(19)30524-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 World Health Organization; licensee Elsevier.","name":"copyright","label":"Copyright"}]}}